FINCH THERAPEUTICS INC has a total of 17 patent applications. It increased the IP activity by 1400.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are NEW PHARMA LICENCE HOLDINGS LTD, PBL MFG LTD and VAXIMM AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | United States | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Republic of Korea | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Climate change adaptation technologies | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Microorganisms | |
#7 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Santiago Marina | 14 |
#2 | Roelofs Kevin | 14 |
#3 | Gerardin Ylaine | 2 |
#4 | Timberlake Sonia | 2 |
#5 | Glettig Dean Liang | 1 |
#6 | De La Serna Eva | 1 |
Publication | Filing date | Title |
---|---|---|
AU2018313765A1 | Compositions and methods for decolonizing antibotic-resistant bacteria in the gut | |
US2020360450A1 | Treatment of liver disease by modulation of the microbiome | |
WO2019032573A1 | Compositions and methods for maintaining and restoring a healthy gut barrier | |
WO2018057747A1 | Pharmaceutical compositions and methods for delivering microbial compositions |